三星医疗：郭粟累计减持公司股票15万股，减持计划实施完毕

Group 1 - Samsung Medical announced the completion of a stock reduction plan, with Guo Su reducing her holdings by 150,000 shares, accounting for approximately 0.01% of the company's total share capital [1] - For the fiscal year 2024, Samsung Medical's revenue composition is as follows: manufacturing accounts for 76.16%, medical services for 22.31%, other businesses for 1.48%, and financial services for 0.04% [1] - As of the report date, Samsung Medical has a market capitalization of 37.5 billion yuan [1]